According to Bloomberg, the president of Isomorphic Labs has stated that artificial intelligence will one day be used to design all drugs. This perspective highlights the growing intersection of artificial intelligence and pharmaceutical research, pointing to a future where computational models could take the lead in developing new therapeutics.